Decision Analysis and Portfolio Management in the Biopharma Industry: A Practitioner's Guide (Hardcover) (ISBN-13: 9781604272147)

Vendor: Richard Bayney
Product type: Books
Format: Hardcover
$99.95
$99.95
$99.95
Subtotal: $99.95
WR Book House

Decision Analysis and Portfolio Management in the Biopharma Industry: A Practitioner's Guide

$99.95

Decision Analysis and Portfolio Management in the Biopharma Industry: A Practitioner's Guide

$99.95
Format: Hardcover
Description
Description
x
Biopharmaceutical R&D stands at a crossroads. Escalating development costs, persistent clinical attrition, heightened competitive pressures, mounting regulatory complexity, and uncertain commercial rewards have made " doing more with less" an inherently flawed strategy for success and sustainability. This one-of-a-kind book reframes the conversation, arguing that the true objective is not simply value creation, but value maximization under risk and uncertainty. By integrating decision analysis with enterprise portfolio management, it provides leaders with the intellectual and operational foundation required to make defensible, high-stakes investment decisions across drug discovery, clinical development, regulatory approval, and commercialization. Grounded in decades of real-world experience, the book builds on CREOPM, first introduced in 2012, as a pragmatic and maturity-sensitive framework designed to embed analytical rigor, strategic clarity, and disciplined governance into the fabric of R&D organizations.

Author: Richard Bayney,Jose Orellana
ISBN-10: 1604272147
ISBN-13: 9781604272147
Publisher: J. Ross Publishing
Language: English
Published: 07/14/2026
Pages: 300
Format: Hardcover
By Richard Bayney
By Richard Bayney
x
Richard Bayney is the President and Founder of Project & Portfolio Value Creation (PPVC), a specialized consulting boutique that delivers an integrated suite of services spanning executive education, decision-support analytics, asset valuation, and R&D portfolio strategy. Through this work, Richard advises organizations on aligning scientific uncertainty, regulatory risk, and capital allocation with long-term strategic and commercial objectives. He has an M.Sc. and Ph.D. from the University of London, an MBA from Columbia University, and a PMP from the Project Management Institute. Jose Orellana is a Senior Business Consultant and Quantitative Solutions Engineer at Lumivero with over 25 years of experience applying numerical modeling to high-stakes decision making. As a globally recognized expert in the DecisionTools Suite and XLSTAT, Jose has advised organizations worldwide on navigating the inherent uncertainties of complex R&D cycles. While his foundational expertise was forged in the demanding engineering environments of Schlumberger and P&G, his work now focuses on the " last mile" of decision analysis-- the critical bridge between raw data and executive strategy.

Recently Viewed Products